z-logo
open-access-imgOpen Access
230 Dosing Strategy for Itacitinib, a Selective JAK1 Inhibitor, for the Treatment of Ulcerative Colitis
Author(s) -
April Barbour,
Yan Zhang,
Naresh Punwani,
Sharon Diamond,
Xuejun Chen,
Swamy Yeleswaram
Publication year - 2019
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000590452.10972.72
Subject(s) - ulcerative colitis , ex vivo , medicine , cmax , in vivo , feces , dosing , pharmacokinetics , gastroenterology , pharmacology , oral administration , biology , microbiology and biotechnology , disease

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here